Mgodi NM, Takuva S, Edupuganti S, Karuna S, et al. A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings. J Acquir Immune Defic Syndr 2021 Feb 11. pii: 00126334-900000000-95944.
PMID: 33587510